Achiko creates and develops new innovations in healthcare technology through its biotechnology division, AptameX, and its sis ... ter digital mobile health technology division, Teman Sehat. The Company has created a unique healthtech capability that provides user-friendly diagnostic testing integrated with a digital passport solution for the management of Covid-19. AptameX comprises DNA aptamer-based technology that is cost-effective, chemically synthesised and widely applicable to the evolving diagnostic field of healthcare. Together with the digital mobile health app Teman Sehat, Achiko is developing potential technologies that seek to deliver rapid, affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications. The AptameX technology is licensed from Regenacellx.sl and Achiko has exclusive commercialisation rights. Headquartered in Zurich, Achiko has offices in Hong Kong, Jakarta, Seoul and Singapore. read more